Home
»
News Listing
Section
Section
▼
News Listing
Search
▼
Search
Date :
To
Department
-- All Department --
Alternative Investment Fund and Foreign Portfolio Investors Department
Board Cell
Communications Department
Corporation Finance Department
Corporation Finance Investigation Department
Department Economic and Policy Analysis
Department of Debt and Hybrid Securities
Enforcement Department - 1
Enquiries and Adjudication Department
General Services Department - 1
General Services Department - 2
General Services Department - 3
Human Resources Department
Information Technology Department
Integrated Surveillance Department
Internal Inspection Department
Investigations Department
Investment Management Department
Legal Affairs Department 1 (LAD 1) Vertical-I
Legal Affairs Department 1 (Vertical 2)
Market Intermediaries Regulation and Supervision Department
Market Regulation Department
National Institute of Securities Markets
Office of International Affairs
Office of Investor Assistance and Education
Office of the Chairperson
Office of WTM
PACL Committtee
Parliament Questions (PQ) Cell & Right to Information (RTI) Cell
Prosecution and Settlement Department
Quasi-Judicial Cell
Recovery and Refund department
Regional Offices
Regulatory Review Cell
SAT - SC Department
Vigilance Department
Section
-- All Section --
Legal
Enforcement
Filings
Reports & Statistics
Media & Notifications
Sub Section
-- All Sub Section --
Sub Sub Section
-- All Sub Section List --
Intermediary
-- All Sub Section List --
Info For
-- All Info for --
Alternative Investment Funds (AIFs)
Bankers to an Issue
Collective Investment Schemes (C.I.S)
Commodity Derivatives
Corp. Debt Market
COVID-19 Measures
Credit Rating Agencies
Debenture Trustees
Depository Participants
Derivatives
Electronic Gold Receipts
Foreign Portfolio Investors (FPI)
Infrastructure Investment Trusts (InvITs)
International Affairs
Investigation
Investment Advisers
Investor Survey
Issues And Listing
Legal Affairs
Listing Regulations
Merchant Bankers
Municipal Debt Securities
Mutual Fund
Portfolio Managers
Prosecution
Real Estate Investment Trusts (REITs)
Registrars to an Issue and Share Transfer Agents
Research Analysts
Stock Brokers
Takeover
Trading, etc
Underwriters
Venture Capital
GO
Reset
1 to 25 of 667 records
1
2
3
4
5
6
Date
Type
Title
Jun 26, 2026
Public Issues
Ujin Pharma Ltd. - DRHP
Ujin Pharma Ltd- Draft Abridged Prospectus
Jun 11, 2026
Public Issues
Goldline Pharmaceutical Limited
Jun 11, 2026
Public Issues
Goldline Pharmaceutical Limited
Jun 08, 2026
Takeovers
Parmax Pharma Limited
May 23, 2026
Takeovers
Bliss GVS Pharma Limited
May 18, 2026
Mutual Funds
ICICI Prudential Nifty Pharma ETF
Apr 29, 2026
Buybacks
Jagsonpal Pharmaceuticals Limited
Apr 08, 2026
Buybacks
Aurobindo Pharma Limited
Mar 17, 2026
Recovery Proceedings
Release order for Recovery Certificate No 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C) in the matter of Venmax Drugs and Pharmaceuticals Limited
Mar 17, 2026
Recovery Proceedings
Completion of Recovery Certificate No 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C) in the matter of Venmax Drugs and Pharmaceuticals Limited
Mar 12, 2026
Mutual Funds
Invesco India Pharma and Healthcare Fund
Mar 06, 2026
Recovery Proceedings
Prohibitory order - Recovery Certificate No. 2885 of 2020 issued against Lars Walan in the matter of Astrazeneca Pharma India Ltd.
Mar 02, 2026
Recovery Proceedings
Prohibitory order - Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited.
Mar 02, 2026
Recovery Proceedings
Modification of General Remittance Order– RC no 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited.
Mar 02, 2026
Recovery Proceedings
Modification of Notice of Attachment– RC no 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited.
Jan 20, 2026
Public Issues
Rodec Pharma Limited
Jan 16, 2026
Orders
Order in the matter of Biowin Pharma (India) Ltd. (in Liquidation) [OLR No. 160 of 2025 in CP No. 775 of 2001]
Jan 07, 2026
Orders
Adjudication Order in the matter of Accretion Pharmaceuticals Limited
Dec 24, 2025
Public Issues
Symbiotec Pharmalab Limited - DRHP
Nov 26, 2025
Public Issues
Sudeep Pharma Limited - Prospectus
Nov 21, 2025
Recovery Proceedings
Certificate of Completion dated November 21, 2025 issued under RC No. 746 of 2015 drawn against Bela H. Kayastha in the matter of Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd. and Tasc Pharmaceuticals.
Nov 21, 2025
Recovery Proceedings
Release Order dated November 21, 2025 issued under RC No. 746 of 2015 drawn against Bela H. Kayastha in the matter of Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd. and Tasc Pharmaceuticals.
Nov 18, 2025
Public Issues
Sudeep Pharma Limited - RHP
Oct 16, 2025
Public Issues
APTUS PHARMA LIMITED
Oct 13, 2025
Public Issues
APTUS PHARMA LIMITED
1 to 25 of 667 records
1
2
3
4
5
6
×
Login
Remember me
Please fill the captcha code
Submit
Reset
Forgot Password ?
|
Subscription for email updates from SEBI